Linking HIV-infected TB patients to cotrimoxazole prophylaxis and antiretroviral treatment in India

PLoS ONE

Volumn 4, Issue 6, 2009, Pages

  Raizada, Neeraj ^a   Chauhan, Lakbir Singh ^b   Babu, B Sai ^c   Thakur, Rahul ^a   Khera, Ajay ^b   Wares, D Fraser ^a   Sahu, Suvanand ^a   Bachani, D ^b   Rewari, B B ^b   Dewan, Puneet K ^d  

^a Office of the WHO Representative to India   (India)

^b GOVERNMENT OF INDIA   (India)

^c Government of Andhra Pradesh   (India)

^d WORLD HEALTH ORGANIZATION   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; COTRIMOXAZOLE; ETHAMBUTOL; ISONIAZID; PYRAZINAMIDE; RIFAMPICIN; STREPTOMYCIN; ANTIINFECTIVE AGENT;

ADOLESCENT; ADULT; AGED; ARTICLE; CHEMOPROPHYLAXIS; CHILD; CLINICAL EFFECTIVENESS; DEATH; DISEASE ASSOCIATION; DRUG EFFICACY; DRUG RESPONSE; FEMALE; HEALTH CARE ACCESS; HEALTH CARE AVAILABILITY; HEALTH CARE DELIVERY; HEALTH CARE PLANNING; HEALTH CARE POLICY; HEALTH PROGRAM; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INDIA; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; MORTALITY; PATIENT COMPLIANCE; PATIENT COUNSELING; PATIENT MONITORING; PREVALENCE; RETROSPECTIVE STUDY; RISK REDUCTION; SCHOOL CHILD; SEX DIFFERENCE; MIDDLE AGED; TREATMENT OUTCOME; TUBERCULOSIS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTI-INFECTIVE AGENTS; ANTI-RETROVIRAL AGENTS; CHILD; FEMALE; HIV INFECTIONS; HUMANS; INDIA; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; TRIMETHOPRIM-SULFAMETHOXAZOLE COMBINATION; TUBERCULOSIS;

EID: 67650164839     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0005999     Document Type: Article

References (30)

1. HIV Sentinel Surveillance and HIV Estimation, 2006. New Delhi, India: National AIDS Control Organization, Ministry of Health and Family Welfare, Government of India. http://www.nacoonline.org/Quick_Links/ HIV_Data/ Accessed 06 February, 2008.
2. Global Tuberculosis Control: Surveillance, Planning, Financing: WHO Report 2008. Geneva, Switzerland: World Health Organization, WHO/HTM/TB/ 2008.393 Accessed.
3. El-Sadr WM, Tsiouris SJ (2008) HIV-associated tuberculosis: diagnostic and treatment challenges. Semin Respir Crit Care Med 29: 525-531.
4. Mukadi YD, Maher D, Harries A (2001) Tuberculosis case fatality rates in high HIV prevalence populations in sub-Saharan Africa. Aids 15: 143-152.
5. Narain JP, Lo YR (2004) Epidemiology of HIV-TB in Asia. Indian J Med Res 120: 277-289.
6. Interim Policy on Collaborative TB/HIV Activities. (2004) Geneva, Switzerland: World Health Organization, WHO/HTM/TB/2004.330. http:// data.unaids.org/Publications/IRC-pub06/JC740-HIV-TB_Surveillance_en.pdf Accessed 1 May 2009.
7. Guidelines on cotrimoxazole prophylaxis for HIV-related infections among children, adolescents and adults in resource limited settings. (2006) Geneva: World Health Organization. http://www.who.int/hiv/pub/guidelines/ ctx/en/index.html Accessed 1 May 2009.
8. Anglaret X, Chene G, Attia A, Toure S, Lafont S, et al. (1999) Early chemoprophylaxis with trimethoprim-sulphamethoxazole for HIV-1-infected adults in Abidjan, Cote d'Ivoire: a randomised trial. Cotrimo-CI Study Group. Lancet 353: 1463-1468.
9. Mermin J, Were W, Ekwaru JP, Moore D, Downing R, et al. (2008) Mortality in HIV-infected Ugandan adults receiving antiretroviral treatment and survival of their HIV-uninfected children: a prospective cohort study. Lancet 371: 752-759.
10. Grimwade K, Swingler GH (2006) Cotrimoxazole prophylaxis for opportunistic infections in children with HIV infection. Cochrane Database Syst Rev. CD003508.
11. Trinh TT, Shah NS, Mai HA, Do TN, Duong T, et al. (2007) HIV-associated TB in An Giang Province, Vietnam, 2001-2004: epidemiology and TB treatment outcomes. PLoS ONE 2: e507.
12. Zachariah R, Spielmann MP, Chinji C, Gomani P, Arendt V, et al. (2003) Voluntary counselling, HIV testing and adjunctive cotrimoxazole reduces mortality in tuberculosis patients in Thyolo, Malawi. Aids 17: 1053-1061.
13. Wiktor SZ, Sassan-Morokro M, Grant AD, Abouya L, Karon JM, et al. (1999) Efficacy of trimethoprim-sulphamethoxazole prophylaxis to decrease morbidity and mortality in HIV-1-infected patients with tuberculosis in Abidjan, Cote d'Ivoire: a randomised controlled trial. Lancet 353: 1469-1475.
14. Boeree MJ, Sauvageot D, Banda HT, Harries AD, Zijlstra EE (2005) Efficacy and safety of two dosages of cotrimoxazole as preventive treatment for HIV-infected Malawian adults with new smear-positive tuberculosis. Trop Med Int Health 10: 723-733.
15. National AIDS Control Organization. Guidelines for the Prevention and Management of Common Opportunistic Infections/Malignancies among HIV-infected Adults and Adolescents. (2007) New Delhi, India: Ministry of Health and Family Welfare, Government of India, Accessed 1 May 2009.
16. Swaminathan S, Luetkemeyer A, Srikantiah P, Lin R, Charlebois E, et al. (2006) Antiretroviral therapy and TB. Trop Doct 36: 73-79.
17. Akksilp S, Karnkawinpong O, Wattanaamornkiat W, Viriyakitja D, Monkongdee P, et al. (2007) Antiretroviral therapy during tuberculosis treatment and marked reduction in death rate of HIV-infected patients, Thailand. Emerg Infect Dis 13: 1001-1007.
18. Sanguanwongse N, Cain KP, Suriya P, Nateniyom S, Yamada N, et al. (2008) Antiretroviral therapy for HIV-infected tuberculosis patients saves lives but needs to be used more frequently in Thailand. J Acquir Immune Defic Syndr 48: 181-189.
19. NACO News: A Newsletter of the National AIDS Control Organization (2008) New Delhi, India: Ministry of Health and Family Welfare, Government of India. http://nacoonline.org/upload/naco%20newsletters/ april%20-june08n%20final.pdf Accessed 9 January 2009.
20. National AIDS Control Organization. Antiretroviral Treatment Guidelines for Adults and Adolescents including Post-Exposure Prophylyaxis. (2007) New Delhi, India: Ministry of Health and Family Welfare, Government of India, http://nacoonline.org/upload/Publication/ Treatment%20Care%20and%20-support/ Antiretroviral%20Therapy%20Guidelines%20for%20HIV- Infected%20Adults%20and%20 Adolescents%20Including%20Post-exposure.pdf Accessed 9 January 2009.
21. Technical Operations Guidelines for Tuberculosis Control. (2005) New Delhi, India: Central TB Division, Directorate General of Health Services, Ministry of Health and Family Welfare, Government of India, http://www.tbcindia.org/pdfs/ Technical%20&%20Operational%20guidelines%20for%20TB%20Control.pdf Accessed 1 May 2009.
22. Greenland S (1989) Modeling and variable selection in epidemiologic analysis. Am J Public Health 79: 340-349.
23. Swaminathan S, Deivanayagam CN, Rajasekaran S, Venkatesan P, Padmapriyadarsini C, et al. (2008) Long term follow up of HIV-infected patients with tuberculosis treated with 6-month intermittent short course chemotherapy. Natl Med J India 21: 3-8.
24. Dheda K, Lampe FC, Johnson MA, Lipman MC (2004) Outcome of HIV-associated tuberculosis in the era of highly active antiretroviral therapy. J Infect Dis 190: 1670-1676.
25. Moore D, Liechty C, Ekwaru P, Were W, Mwima G, et al. (2007) Prevalence, incidence and mortality associated with tuberculosis in HIV-infected patients initiating antiretroviral therapy in rural Uganda. Aids 21: 713-719.
26. Jha P, Jacob B, Gajalakshmi V, Gupta PC, Dhingra N, et al. (2008) A nationally representative case-control study of smoking and death in India. N Engl J Med 358: 1137-1147.
27. Kolappan C, Subramani R, Karunakaran K, Narayanan PR (2006) Mortality of tuberculosis patients in Chennai, India. Bull World Health Organ 84: 555-560.
28. Pednekar MS, Gupta PC (2007) Prospective study of smoking and tuberculosis in India. Prev Med 44: 496-498.
29. Raizada N, Chauhan LS, Khera A, Sokhey J, Wares DF, et al. (2008) HIV seroprevalence among tuberculosis patients in India, 2006-2007. PLoS ONE 3: e2970.
30. National Framework for Joint TB/HIV Collaborative Activities: February 2008. New Delhi, India: Ministry of Health and Family Welfare, Government of India, http://www.tbcindia.org Accessed 1 May 2009.